In the current study, by increasing the number of enrolled subjects approximately nine-fold, we have demonstrated a significant association between FGF23 and LVH or low LVEF among patients with CKD stage G1/G2 after adjustment for various factors not included in the previous study, such as history of hypertension, diuretic use, and CRP. This evidence concerns the gene CRP and Hypertension.